Anti-epileptic Drugs for Pediatrics Market Research: Global Status & Forecast by Geography, Type & Application (2017-2027)

According to 99Strategy, the Global Anti-epileptic Drugs for Pediatrics Market is estimated to reach xxx million USD in 2021 and projected to grow at the CAGR of xx% during the 2022-2027. The report analyses the global Anti-epileptic Drugs for Pediatrics market, the market size and growth, as well a...

10/28/2021 | Drugs

Anti-ulcer Drug Market Research: Global Status & Forecast by Geography, Type & Application (2017-2027)

According to 99Strategy, the Global Anti-ulcer Drug Market is estimated to reach xxx million USD in 2021 and projected to grow at the CAGR of xx% during the 2022-2027. The report analyses the global Anti-ulcer Drug market, the market size and growth, as well as the major market participants. The ana...

10/28/2021 | Drugs

Weight Loss Drugs Market Research: Global Status & Forecast by Geography, Type & Application (2017-2027)

According to 99Strategy, the Global Weight Loss Drugs Market is estimated to reach xxx million USD in 2021 and projected to grow at the CAGR of xx% during the 2022-2027. The report analyses the global Weight Loss Drugs market, the market size and growth, as well as the major market participants. The...

7/7/2021 | Drugs

Weight Loss Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segment...

2/4/2021 | Drugs

Musculoskeletal Disorders Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segment...

1/30/2021 | Drugs

Multiple Sclerosis (MS) Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segment...

1/30/2021 | Drugs

Cedar Pollen Allergy Drug Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segment...

1/23/2021 | Drugs

Hereditary Angioedema Drug Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segment...

1/17/2020 | Drugs

The World Market for Orthopedic or Fracture Appliances and Artificial Joints: A 2021 Global Trade Perspective

This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for orthopedic or fracture appliances and artificial joints. With the globalization of this market, managers can no longer be contented with a local view. Nor can ma...

9/4/2020 | Healthcare, Drugs, Pharmaceuticals, Hospitals, and Laboratories

The World Market for Artificial Teeth and Dental Fittings: A 2021 Global Trade Perspective

This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for artificial teeth and dental fittings. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented...

9/4/2020 | Healthcare, Drugs, Pharmaceuticals, Hospitals, and Laboratories

First
Previous
1
2
3
4
5
6
7
8
9
10
Next

According to 99Strategy, the Global Anti-epileptic Drugs for Pediatrics Market is estimated to reach xxx million USD in 2021 and projected to grow at the CAGR of xx% during the 2022-2027. The report analyses the global Anti-epileptic Drugs for Pediatrics market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report. Key Regions Asia Pacific North America Europe South America Middle East & Africa Key Companies Mylan N.V. Cephalon, Inc. GlaxoSmithKline plc Janssen Pharmaceuticals Novartis AG Pfizer, Inc. Sanofi S.A. UCB Pharma Limited Sunovion Pharmaceuticals Limited Valeant Pharmaceuticals International, Inc. Zogenix GW Pharmaceuticals Insys Zynerba Key Product Type First Generation Second Generation Third Generation Market by Application Clinic Hospital Others Main Aspects covered in the Report Overview of the Anti-epileptic Drugs for Pediatrics market including production, consumption, status & forecast and market growth 2017-2021 historical data and 2022-2027 market forecast Geographical analysis including major countries Overview the product type market including development Overview the end-user market including development ...

10/28/2021

According to 99Strategy, the Global Anti-ulcer Drug Market is estimated to reach xxx million USD in 2021 and projected to grow at the CAGR of xx% during the 2022-2027. The report analyses the global Anti-ulcer Drug market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report. Key Regions Asia Pacific North America Europe South America Middle East & Africa Key Companies Eisai Daewoong Pharmaceutical Takeda HeliCure AstraZeneca Ore Pharmaceuticals Sihuan Pharmaceutical Key Product Type Sodium?Bicarbonate Magnesium?Trisilicate Others Market by Application Hospital Medical Center Others Main Aspects covered in the Report Overview of the Anti-ulcer Drug market including production, consumption, status & forecast and market growth 2017-2021 historical data and 2022-2027 market forecast Geographical analysis including major countries Overview the product type market including development Overview the end-user market including development ...

10/28/2021

According to 99Strategy, the Global Weight Loss Drugs Market is estimated to reach xxx million USD in 2021 and projected to grow at the CAGR of xx% during the 2022-2027. The report analyses the global Weight Loss Drugs market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report. Key Regions Asia Pacific North America Europe South America Middle East & Africa Key Companies Roche GSK group Teva Sandoz(Novartis) STADA-VN J.V.Co., Ltd Hexal AG National Company For Pharmaceutical Industry Lunan Pharmaceutical Group Corporation Zein Pharmaceutical Hisun Taj Pharmaceuticals Ltd Kabir Life Sciences & Research Dm Pharma China Zhongshan Pharm Key Product Type Liauid Tablets Market by Application Weight-reducing Aid Other Main Aspects covered in the Report Overview of the Weight Loss Drugs market including production, consumption, status & forecast and market growth 2017-2021 historical data and 2022-2027 market forecast Geographical analysis including major countries Overview the product type market including development Overview the end-user market including development ...

7/7/2021

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segmentation by region, type and End-Use Chapter 6: Europe Market Segmentation by region, type and End-Use Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use Chapter 8: South America Market Segmentation by region, type and End-Use Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use. Chapter 10: Market Competition by Companies Chapter 11: Market forecast and environment forecast. Chapter 12: Industry Summary. The global Weight Loss Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics. Based on the type of product, the global Weight Loss Drugs market segmented into Liauid Tablets Based on the end-use, the global Weight Loss Drugs market classified into Weight-reducing Aid Other Based on geography, the global Weight Loss Drugs market segmented into North America [U.S., Canada, Mexico] Europe [Germany, UK, France, Italy, Rest of Europe] Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific] South America [Brazil, Argentina, Rest of Latin America] Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa] And the major players included in the report are Roche GSK group Teva Sandoz(Novartis) STADA-VN J.V.Co., Ltd Hexal AG National Company For Pharmaceutical Industry Lunan Pharmaceutical Group Corporation Zein Pharmaceutical Hisun Taj Pharmaceuticals Ltd Kabir Life Sciences & Research Dm Pharma China Zhongshan Pharm ...

2/4/2021

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segmentation by region, type and End-Use Chapter 6: Europe Market Segmentation by region, type and End-Use Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use Chapter 8: South America Market Segmentation by region, type and End-Use Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use. Chapter 10: Market Competition by Companies Chapter 11: Market forecast and environment forecast. Chapter 12: Industry Summary. The global Musculoskeletal Disorders Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics. Based on the type of product, the global Musculoskeletal Disorders Drugs market segmented into Rheumatoid Arthritis Muscle Relaxants Others Based on the end-use, the global Musculoskeletal Disorders Drugs market classified into Rheumatoid Arthritis Osteoarthritis Osteoporosis Psoriatic Arthritis Ankylosing Spondylitis Others Based on geography, the global Musculoskeletal Disorders Drugs market segmented into North America [U.S., Canada, Mexico] Europe [Germany, UK, France, Italy, Rest of Europe] Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific] South America [Brazil, Argentina, Rest of Latin America] Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa] And the major players included in the report are AbbVie Amgen Johnson & Johnson F. Hoffmann-La Roche Ltd Pfizer Inc Eli Lilly ...

1/30/2021

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segmentation by region, type and End-Use Chapter 6: Europe Market Segmentation by region, type and End-Use Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use Chapter 8: South America Market Segmentation by region, type and End-Use Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use. Chapter 10: Market Competition by Companies Chapter 11: Market forecast and environment forecast. Chapter 12: Industry Summary. The global Multiple Sclerosis (MS) Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics. Based on the type of product, the global Multiple Sclerosis (MS) Drugs market segmented into Copaxone (Glatiramer Acetate, Copolymer 1) Novantrone (Mitoxantrone) Gilenya (Fingolimod, Fty720) Aubagio (Teriflunomide) Tecfidera (Dimethyl Fumarate) Firategrast (Sb683699, T-0047) Siponimod (Baf312) Others Based on the end-use, the global Multiple Sclerosis (MS) Drugs market classified into RRMS SPMS PPMS PRMS Based on geography, the global Multiple Sclerosis (MS) Drugs market segmented into North America [U.S., Canada, Mexico] Europe [Germany, UK, France, Italy, Rest of Europe] Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific] South America [Brazil, Argentina, Rest of Latin America] Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa] And the major players included in the report are Bayer AG Bayhill Therapeutics Biogen Idec Cinnagen Daiichi Sankyo Eli Lilly Fast Forward Llc Antisense Therapeutics Apitope Five Prime Therapeutics Genmab Artielle Immunotherapeutics Genzyme Glaxosmithkline Gw Pharmaceuticals Innate Immunotherapeutics ...

1/30/2021

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segmentation by region, type and End-Use Chapter 6: Europe Market Segmentation by region, type and End-Use Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use Chapter 8: South America Market Segmentation by region, type and End-Use Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use. Chapter 10: Market Competition by Companies Chapter 11: Market forecast and environment forecast. Chapter 12: Industry Summary. The global Cedar Pollen Allergy Drug market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics. Based on the type of product, the global Cedar Pollen Allergy Drug market segmented into RGI-1001 STG-120 TO-206 Others Based on the end-use, the global Cedar Pollen Allergy Drug market classified into Out-Patient In-Patient Based on geography, the global Cedar Pollen Allergy Drug market segmented into North America [U.S., Canada, Mexico] Europe [Germany, UK, France, Italy, Rest of Europe] Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific] South America [Brazil, Argentina, Rest of Latin America] Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa] And the major players included in the report are ALK-Abello A/S Anergis SA Circassia Pharmaceuticals Plc Immunomic Therapeutics, Inc. Japan Tobacco Inc. REGiMMUNE Corporation ...

1/23/2021

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segmentation by region, type and End-Use Chapter 6: Europe Market Segmentation by region, type and End-Use Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use Chapter 8: South America Market Segmentation by region, type and End-Use Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use. Chapter 10: Market Competition by Companies Chapter 11: Market forecast and environment forecast. Chapter 12: Industry Summary. The global Hereditary Angioedema Drug market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics. Based on the type of product, the global Hereditary Angioedema Drug market segmented into By Product C1 Esterase Inhibitor Kallikrein Inhibitor Selective Bradykinin B2 Receptor Antagonist By Route of Administration Oral Intravenous Subcutaneous Injection Based on the end-use, the global Hereditary Angioedema Drug market classified into Retail Pharmacies Hospital Pharmacies Online Pharmacies Based on geography, the global Hereditary Angioedema Drug market segmented into North America [U.S., Canada, Mexico] Europe [Germany, UK, France, Italy, Rest of Europe] Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific] South America [Brazil, Argentina, Rest of Latin America] Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa] And the major players included in the report are Pharming Group NV Shire plc CSL Limited iBio Inc. BioCryst Pharmaceuticals, Inc. Ionis Pharmaceuticals, Inc. ...

1/17/2020

9/4/2020

9/4/2020

LATEST REPORTS

PRESS RELEASES

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT